Never miss a story

Get subscribed to our newsletter


×
Pancreatic Cancer treatment. Flickr

Researchers have identified a protein that may represent a novel therapeutic target for the treatment of pancreatic cancer. Using this protein as a target, the team successfully created a CAR T cell therapy — a type of immunotherapy — that killed pancreatic cancer cells in a pre-clinical model.

“This is an exciting development,” said John Marshall, Professor from the Queen Mary University of London.


Follow NewsGram on Facebook to stay updated.

“Finding that CEACAM7 allows us to kill pancreatic cancer cells specifically with CAR T cells while having no significant toxicity in non-tumor tissues, gives us hope that this strategy could be effective in the future,” Marshall added.

CAR T cell therapy is an immunotherapy that has shown great promise for the treatment of some blood cancers; however, the treatment of solid tumors using this therapy has proved very difficult. One barrier to success is toxicity in tissues other than cancer because most of the proteins currently used to target CAR T cells to pancreatic cancer cells and other solid tumors are present in low levels on other normal tissues, leading to toxic side effects, the researchers said.


A novel therapeutic target for the treatment of pancreatic cancer. Pixabay

In this study, published in the journal Clinical Cancer Research, the team identified a protein called CEACAM7 that may represent a safer treatment target for the development of therapies against pancreatic ductal adenocarcinoma (PDAC), the most common type of pancreatic cancer.

ALSO READ: Here’s How COVID Vaccines Have Opened Way For Cancer, Other Disease Treatments

By using a specialized technique called immunostaining, the team examined a panel of human PDAC samples and normal tissues for the presence of CEACAM7. A large subset of PDAC samples tested expressed CEACAM7, but the protein was undetectable in a panel of normal tissues including tonsil, lung, liver, and prostate, suggesting that CEACAM7 may be an ideal target for CAR T cell development against pancreatic cancer.

To determine the potential of CEACAM7 as a treatment target, the team developed CAR T cells targeted to CEACAM7 and applied these to PDAC cell lines as well as a preclinical model of PDAC. The CAR T cells effectively targeted the CEACAM7-expressing cells in PDAC cell cultures and eliminated cancer cells in a late-stage preclinical model of PDAC. (IANS)


Popular

VOA

Bottles of Jack Daniel's whiskeys are displayed at Rossi's Deli in San Francisco

Jack Daniel's is the world's most popular whiskey brand, but until recently, few people knew the liquor was created by Nathan "Nearest" Green, an enslaved Black man who mentored Daniel.

"We've always known," says Debbie Staples, a great-great-granddaughter of Green's who heard the story from her grandmother. … "He made the whiskey, and he taught Jack Daniel. And people didn't believe it … it's hurtful. I don't know if it was because he was a Black man."

Keep Reading Show less
Photo by Aksh yadav on Unsplash

Cricket fans can now book the ultimate experience with the official accommodation booking partner for the ICC Men's T20 World Cup

Cricket fans can now book the ultimate experience with the official accommodation booking partner for the ICC Men's T20 World Cup, Booking.com. The T20 Pavillion, a bespoke cricket-themed luxury stay that transforms the Presidential Suite at Grand Hyatt Mumbai Hotel and Residences into a classic cricket stadium.


The suite offers guests an all-inclusive once-in-a-lifetime experience during the India vs Pakistan ICC Men's T20 World Cup match on October 24, 2021, packed with quirks and luxuries that is sure to satisfy even the biggest cricket enthusiast. Additionally, as a part of the experience, guests will also have the exclusive opportunity to meet Bollywood actor Shraddha Kapoor at The T20 Pavilion.

Keep Reading Show less
Photo by CDC on Unsplash

The findings from preliminary studies on possible stem cell-based Covid-19 treatments are frequently being exaggerated through press releases, social media and uncritical news media reports.

Amid the rush to find quick treatments for Covid-19 last year, the world saw a global race to find new stem cell-based treatments. Now, researchers report that such therapies were filled with violations of government regulations, inflated medical claims and distorted public communication. There are reports of patients suffering physical harm -- including blindness and death -- from unproven stem cell therapies.

"Efforts to rapidly develop therapeutic interventions should never occur at the expense of the ethical and scientific standards that are at the heart of responsible clinical research and innovation," said lead study author Laertis Ikonomou, associate professor of oral biology at University at Buffalo, New York. There are clinics offering unproven and unsafe "stem cell" therapies that promise to prevent Covid-19 by strengthening the immune system or improving overall health, the researchers noted in the paper published in the journal Stem Cell Reports.

Keep reading... Show less